Sanofi in $50m oncology collaboration

19-07-2018

Sanofi in $50m oncology collaboration

Xesai / iStockphoto.com

Sanofi has partnered with biotechnology company Revolution Medicines to develop treatments for multiple cancers.


Sanofi, Revolution Medicines, oncology, research and development, global partnership, drug commercialisation, global licensing agreement, cancer therapy

LSIPR